Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
FLDM Fluidigm Corporation daily Stock Chart
FLDM [NASD]
Fluidigm Corporation
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E- EPS (ttm)-2.45 Insider Own0.80% Shs Outstand29.75M Perf Week-0.96%
Market Cap153.21M Forward P/E- EPS next Y-1.61 Insider Trans- Shs Float29.03M Perf Month45.07%
Income-71.60M PEG- EPS next Q-0.54 Inst Own95.30% Short Float5.83% Perf Quarter32.05%
Sales96.70M P/S1.58 EPS this Y-36.40% Inst Trans-3.28% Short Ratio4.74 Perf Half Y-8.04%
Book/sh0.82 P/B6.28 EPS next Y24.40% ROA-23.90% Target Price5.33 Perf Year-40.32%
Cash/sh1.41 P/C3.65 EPS next 5Y-8.06% ROE-156.00% 52W Range2.52 - 8.69 Perf YTD-29.26%
Dividend- P/FCF- EPS past 5Y-7.60% ROI-27.80% 52W High-40.74% Beta3.36
Dividend %- Quick Ratio1.80 Sales past 5Y19.50% Gross Margin53.00% 52W Low104.77% ATR0.29
Employees589 Current Ratio2.30 Sales Q/Q-15.20% Oper. Margin-72.60% RSI (14)60.74 Volatility5.95% 6.67%
OptionableYes Debt/Eq8.16 EPS Q/Q10.30% Profit Margin-74.00% Rel Volume0.42 Prev Close4.93
ShortableYes LT Debt/Eq8.16 EarningsAug 03 AMC Payout- Avg Volume357.15K Price5.15
Recom3.00 SMA205.68% SMA5025.05% SMA200-2.79% Volume151,771 Change4.46%
Aug-05-16Reiterated Mizuho Buy $11 → $12
Aug-05-16Reiterated Cantor Fitzgerald Buy $13 → $11
May-05-16Reiterated Mizuho Buy $8 → $11
Apr-12-16Reiterated Leerink Partners Outperform $20 → $15
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
Feb-03-14Reiterated Oppenheimer Outperform $46 → $52
Jan-14-14Reiterated Mizuho Neutral $30 → $43
Dec-18-13Reiterated Maxim Group Buy $33 → $42
Oct-31-13Reiterated Mizuho Neutral $19 → $30
Oct-31-13Reiterated Maxim Group Buy $26 → $33
Aug-28-17 04:05PM  Fluidigm to Participate in Two Upcoming Health Care Conferences in September GlobeNewswire
Aug-25-17 04:26PM  ETFs with exposure to Fluidigm Corp. : August 25, 2017 Capital Cube +14.99%
Aug-18-17 07:47AM  Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics Zacks
Aug-17-17 04:05PM  Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System GlobeNewswire
Aug-16-17 11:09AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-11-17 06:50PM  Edited Transcript of FLDM earnings conference call or presentation 3-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-10-17 07:20PM  Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering GlobeNewswire +5.96%
Aug-05-17 01:10AM  Fluidigm reports 2Q loss Associated Press
Aug-03-17 04:05PM  Fluidigm Announces Second Quarter Financial Results and Operational Progress GlobeNewswire
02:30PM  Investor Network: Fluidigm Corporation to Host Earnings Call ACCESSWIRE
Aug-02-17 06:00AM  Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan GlobeNewswire -5.25%
Jul-27-17 04:05PM  Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China GlobeNewswire
Jul-20-17 04:05PM  Fluidigm to Report Q2 2017 Financial Results and Host Conference Call GlobeNewswire
Jul-18-17 09:00AM  Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research GlobeNewswire -8.10%
Jul-10-17 02:29PM  ETFs with exposure to Fluidigm Corp. : July 10, 2017 Capital Cube
Jun-16-17 03:47PM  ETFs with exposure to Fluidigm Corp. : June 16, 2017 Capital Cube
Jun-02-17 02:08PM  ETFs with exposure to Fluidigm Corp. : June 2, 2017 Capital Cube
May-23-17 08:50PM  Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents -10.35%
May-15-17 03:44PM  ETFs with exposure to Fluidigm Corp. : May 15, 2017 Capital Cube
May-12-17 10:37AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
May-10-17 08:40PM  Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-05-17 05:02AM  Fluidigm reports 1Q loss Associated Press +17.53%
May-04-17 04:10PM  European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research GlobeNewswire
04:05PM  Fluidigm Announces First Quarter Financial Results GlobeNewswire
01:25PM  Investor Network: Fluidigm Corporation to Host Earnings Call Accesswire
Apr-28-17 06:54AM  Cerner (CERN) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-27-17 09:46AM  CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y Zacks
Apr-20-17 04:05PM  Fluidigm to Report Q1 2017 Financial Results and Host Conference Call GlobeNewswire
Apr-07-17 10:06AM  Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System Zacks
09:49AM  Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital Zacks
Apr-06-17 10:34AM  Mazor Expects Higher Q1 Revenue, Receives Mazor X Orders Zacks +8.04%
Apr-05-17 10:24AM  Teleflex (TFX) Acquires Medical Device Provider Pyng Medical Zacks
10:16AM  Becton, Dickinson Takes Over Caesarea Medical Electronics Zacks
Apr-03-17 10:13AM  Varian (VAR) Eclipse Software Tops in International Studies Zacks -7.56%
Mar-31-17 11:11AM  PAREXEL (PRXL) Launches Sensor for Clinical Trial Market Zacks
11:04AM  AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View Zacks
Mar-30-17 11:14AM  Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering Zacks
11:14AM  Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering at Investopedia
11:11AM  Envision (EVHC) Teams Up with Lyft to Focus on Transportation Zacks
11:11AM  Envision (EVHC) Teams Up with Lyft to Focus on Transportation at Investopedia
08:56AM  Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife Zacks
08:56AM  Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife at Investopedia
Mar-29-17 09:30AM  Zacks.com featured highlights: United Bankshares, TopBuild, WSFS Financial, Fluidigm and Otter Tail Zacks
09:30AM  Zacks.com featured highlights: United Bankshares, TopBuild, WSFS Financial, Fluidigm and Otter Tail at Investopedia
09:04AM  Intuitive Surgical Hits 52-Week High on Multiple Positives
09:04AM  Intuitive Surgical Hits 52-Week High on Multiple Positives
08:32AM  Akers Receives Cholesterol Test Kit Order from First Check
Mar-28-17 09:39AM  Henry Schein (HSIC) Poised on Solid Growth, Risks Remain
09:29AM  BioScrip (BIOS) Stock Declines on Dull Q1 EBITDA Outlook
09:08AM  Evolent Health (EVH) Prices 7.5M Follow-On Share Offering
Mar-27-17 04:13PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:05PM  Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors GlobeNewswire
08:53AM  DexCom Gains as CMS Announces Criteria for G5 Mobile CGM
Mar-23-17 12:26PM  Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering +5.14%
Mar-22-17 08:58AM  HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates
08:50AM  DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?
08:32AM  Neogen (NEOG) Earnings and Revenues Meet Estimates in Q3
Mar-21-17 11:02AM  Merit Medical (MMSI) to Refinance Debt via Share Offering
Mar-20-17 09:11AM  Mazor Robotics-Medtronic's Mazor X Partnership Strengthens +5.44%
09:05AM  Fresenius (FMS) to Jointly Develop Acumen with Epic Systems
Mar-17-17 11:32AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
10:14AM  Air Methods (AIRM) Opens New Training Facility in Colorado
Mar-15-17 11:19AM  Patterson (PDCO) Rewards Shareholders with 8% Dividend Hike
11:10AM  Air Methods (AIRM) Set to be Acquired for $2.5 Billion
10:10AM  Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty
Mar-13-17 09:30AM  ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI
Mar-10-17 09:05AM  Cogentix (CGNT) Q4 Earnings and Revenues Miss Estimates
Mar-09-17 10:41AM  Cooper Companies (COO) Receives ISO 15189 Accreditation
10:40AM  C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain
Mar-08-17 01:04PM  FLUIDIGM CORP Financials -6.23%
Mar-07-17 10:51AM  TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4 -7.77%
Mar-03-17 06:09AM  FLUIDIGM CORP Files SEC form 10-K, Annual Report -5.67%
Mar-02-17 04:26PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers -6.62%
Mar-01-17 08:58AM  Inogen (INGN) Tops Earnings & Revenues in Q4; View Upbeat
07:58AM  Integer (ITGR) Beats Earnings and Revenue Estimates in Q4
Feb-28-17 01:30PM  Allscripts Launches Clinical Pathways for Cancer Treatment
Feb-23-17 04:05PM  Fluidigm to Present at Cowen and Company 37th Annual Health Care Conference GlobeNewswire
02:02PM  Patterson Companies (PDCO) Earnings Beat Estimates in Q3
10:04AM  Fresenius Medical (FMS) Tops Earnings in Q4, View Upbeat
09:55AM  Inovalon (INOV) Q4 Earnings In Line, Revenue Beat Estimates
Feb-22-17 08:26AM  Wright Medical (WMGI) Posts Narrower-than-Expected Q4 Loss
08:18AM  DaVita (DVA) Ties Up with Cigna Arm, Expands in Los Angeles
Feb-17-17 09:34AM  DENTSPLY (XRAY) Beats on Earnings in Q4, Misses Revenues
07:59AM  DaVita (DVA) Earnings Beat Estimates, Revenues Lag in Q4
Feb-16-17 08:53AM  CryoLife (CRY) Earnings Beat Estimates, Revenues Lag in Q4
Feb-14-17 01:19PM  Fluidigm Corp. :FLDM-US: Earnings Analysis: 2016 By the Numbers : February 14, 2017 +9.25%
09:47AM  Varian (VAR) Eclipse Software Named Category Leader by KLAS
Feb-10-17 05:21PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:06AM  Cerner (CERN) Q4 Earnings Meet, Revenues Miss Estimates
Feb-08-17 09:58PM  Edited Transcript of FLDM earnings conference call or presentation 8-Feb-17 10:00pm GMT
05:14PM  Fluidigm reports 4Q loss
04:45PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Fluidigm Announces Q4 and Full Year 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Fluidigm Corp Earnings Release - After Market Close
Jan-25-17 04:05PM  Fluidigm to Report Q4 and Full Year 2016 Financial Results and Host Conference Call GlobeNewswire
Jan-12-17 07:47AM  Fluidigm: Q4 Preliminary Results Fail to Cheer Investors
Jan-11-17 04:11PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-09-17 05:31PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial
04:15PM  Fluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year Ended December 31, 2016 GlobeNewswire
Dec-22-16 08:20AM  Fluidigm Unveils High-Throughput Integrated Fluidic Circuit
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 systems; integrated fluidic circuits (IFCs) consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. The company also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules. It serves academic institutions; clinical research laboratories; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations. Fluidigm Corporation distributes its systems through direct sales force and support organizations located in North America, Europe, and the Asia-Pacific, and through distributors or sales agents in various European, Latin American, Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 12Buy5.2560,000314,70010,134,731Sep 14 04:40 PM
LEE JENNIFER LINGSee RemarksAug 21Option Exercise0.001,75504,089Aug 23 05:06 PM
Linthwaite Stephen ChristopherPresident & CEOAug 21Option Exercise0.004,7500111,727Aug 23 05:07 PM
Khadder NicholasSee RemarksAug 21Option Exercise0.005,12506,656Aug 23 05:05 PM
Yow Mai ChanSee RemarksAug 21Option Exercise0.002,395015,033Aug 23 05:06 PM
McPhail StevenChief Commercial OfficerAug 21Option Exercise0.002,397030,239Aug 23 05:06 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 21Option Exercise0.003,150010,661Aug 23 05:06 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 17Buy3.664651,70110,122,581Aug 18 02:13 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 09Buy3.181,5494,9326,334,209Aug 11 04:39 PM
Linthwaite Stephen ChristopherPresident & CEOAug 08Buy2.6645,000119,885106,977Aug 08 08:35 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 08Buy2.7150,000135,30552,061Aug 08 08:33 PM
COLELLA SAMUEL DDirectorAug 08Buy2.7735,89599,35753,395Aug 08 08:30 PM
McPhail StevenChief Commercial OfficerAug 08Buy3.0020,00060,03227,842Aug 08 08:29 PM
COLELLA SAMUEL DDirectorJul 31Option Exercise0.005,000045,197Aug 02 08:39 PM
YOUNG JOHN ADirectorJul 31Option Exercise0.005,00005,849Aug 02 08:35 PM
JONES PATRICK SDirectorJul 31Option Exercise0.005,00005,000Aug 02 08:36 PM
JONES EVAN/ FADirectorJul 31Option Exercise0.005,000058,551Aug 02 08:34 PM
Burbach Gerhard FDirectorJul 31Option Exercise0.005,00005,000Aug 02 08:33 PM
JONES EVAN/ FADirectorJun 07Sale4.411,4006,16753,551Jun 08 07:31 PM
JONES EVAN/ FADirectorJun 06Sale4.569,50043,34454,951Jun 08 07:31 PM
Linthwaite Stephen ChristopherPresident & CEOMay 22Option Exercise0.006,333064,333May 23 06:59 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMay 22Option Exercise0.003,87008,933May 23 06:58 PM
LEE JENNIFER LINGSee RemarksMay 22Option Exercise0.004,01904,019May 23 06:57 PM
Khadder NicholasSee RemarksMay 22Option Exercise0.002,63302,633May 23 06:55 PM
McPhail StevenChief Commercial OfficerMay 22Option Exercise0.002,82408,749May 23 06:53 PM
Yow Mai ChanSee RemarksMay 22Option Exercise0.002,798012,638May 23 06:52 PM
COLELLA SAMUEL DDirectorMay 09Buy5.937,50044,43817,500May 11 06:08 PM
COLELLA SAMUEL DDirectorMar 14Buy5.0010,00049,97310,000Mar 15 02:24 PM
COLELLA SAMUEL DDirectorDec 14Buy7.395,00036,93544,123Dec 14 07:05 PM
Linthwaite Stephen ChristopherPresident & CEONov 30Buy6.3655,000350,06458,000Dec 02 04:19 PM
COLELLA SAMUEL DDirectorNov 30Buy6.3220,000126,47039,123Dec 02 04:18 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 07Buy4.386,00026,3096,343,743Nov 07 06:25 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 04Buy4.4211,78452,1046,337,743Nov 07 06:25 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 03Buy4.44141,416628,1586,325,959Nov 07 06:25 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 02Buy4.4717,40077,6966,184,543Nov 03 03:35 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 01Buy4.4330,902136,8356,167,143Nov 03 03:35 PM
open in yahoo | open in reuters | open in google